Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancerSCHEIERMANN, Julia; KLINMAN, Dennis M.Vaccine. 2014, Vol 32, Num 48, pp 6377-6389, issn 0264-410X, 13 p.Article

Recent progress concerning CpG DNA and its use as a vaccine adjuvantSHIROTA, Hidekazu; KLINMAN, Dennis M.Expert review of vaccines. 2014, Vol 13, Num 2, pp 299-312, issn 1476-0584, 14 p.Article

Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primatesVERTHELYI, Daniela; KLINMAN, Dennis M.Clinical immunology (Orlando, Fla. Print). 2003, Vol 109, Num 1, pp 64-71, issn 1521-6616, 8 p.Article

CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunitySHIROTA, Hidekazu; KLINMAN, Dennis M.Cancer immunology and immunotherapy. 2011, Vol 60, Num 5, pp 659-669, issn 0340-7004, 11 p.Article

A single-dose combination therapy that both prevents and treats anthrax infectionKLINMAN, Dennis M; TROSS, Debra.Vaccine. 2009, Vol 27, Num 12, pp 1811-1815, issn 0264-410X, 5 p.Article

Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lungYAMADA, Hiroshi; ISHII, Ken J; KLINMAN, Dennis M et al.Critical care medicine. 2004, Vol 32, Num 10, pp 2045-2049, issn 0090-3493, 5 p.Article

CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicansITO, Shuichi; PEDRAS-VASCONCELOS, Joao; KLINMAN, Dennis M et al.Infection and immunity. 2005, Vol 73, Num 9, pp 6154-6156, issn 0019-9567, 3 p.Article

Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotidesKAMSTRUP, Søren; VERTHELYI, Daniela; KLINMAN, Dennis M et al.Veterinary microbiology (Amsterdam). 2001, Vol 78, Num 4, pp 353-362, issn 0378-1135Article

Heterogeneity in the human response to immunostimulatory CpG oligodeoxynucleotidesLEIFER, Cynthia A; VERTHELYI, Daniela; KLINMAN, Dennis M et al.Journal of immunotherapy (1997). 2003, Vol 26, Num 4, pp 313-319, issn 1524-9557, 7 p.Article

Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW miceLI DONG; SHUICHI ITO; ISHII, Ken J et al.Arthritis and rheumatism. 2005, Vol 52, Num 2, pp 651-658, issn 0004-3591, 8 p.Article

Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenesITO, Shuichi; ISHII, Ken J; IHATA, Atsushi et al.Infection and immunity. 2005, Vol 73, Num 6, pp 3803-3805, issn 0019-9567, 3 p.Article

Contribution of IRF-3 mediated IFNβ production to DNA vaccine dependent cellular immune responsesSHIROTA, Hidekazu; PETRENKO, Lev; HATTORI, Toshio et al.Vaccine. 2009, Vol 27, Num 15, pp 2144-2149, issn 0264-410X, 6 p.Article

Use of CpG oligodeoxynucleotides as immune adjuvantsKLINMAN, Dennis M; CURRIE, Debra; GURSEL, Ihsan et al.Immunological reviews. 2004, Vol 199, pp 201-216, issn 0105-2896, 16 p.Article

Systemic but not mucosal immunity induced by AVA prevents inhalational anthraxKLINMAN, Dennis M; CURRIE, Debra; LEE, Gloria et al.Microbes and infection. 2007, Vol 9, Num 12-13, pp 1478-1483, issn 1286-4579, 6 p.Article

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaquesKLINMAN, Dennis M; HANG XIE; LITTLE, Stephen F et al.Vaccine. 2004, Vol 22, Num 21-22, pp 2881-2886, issn 0264-410X, 6 p.Article

Suppressive oligonucleotides protect against collagen-induced arthritis in miceLI DONG; ITO, Shu-Ichi; ISHII, Ken J et al.Arthritis and rheumatism. 2004, Vol 50, Num 5, pp 1686-1689, issn 0004-3591, 4 p.Article

CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaquesVERTHELYI, Daniela; WANG, Vivian W; LIFSON, Jeffrey D et al.AIDS (London). 2004, Vol 18, Num 7, pp 1003-1008, issn 0269-9370, 6 p.Article

CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infectionITO, Shu-Ichi; ISHII, Ken J; SHIROTA, Hidekazu et al.Infection and immunity. 2004, Vol 72, Num 6, pp 3543-3548, issn 0019-9567, 6 p.Article

Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritisZEUNER, Rainald A; VERTHELYI, Daniela; GURSEL, Mayda et al.Arthritis and rheumatism. 2003, Vol 48, Num 6, pp 1701-1707, issn 0004-3591, 7 p.Article

Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccinationSHIMADA, Masaru; YOSHIZAKI, Shinji; ICHINO, Motohide et al.Vaccine. 2014, Vol 32, Num 40, pp 5198-5205, issn 0264-410X, 8 p.Article

FDA guidance on prophylactic DNA vaccines: Analysis and recommendationsKLINMAN, Dennis M; KLASCHIK, Sven; TROSS, Debra et al.Vaccine. 2010, Vol 28, Num 16, pp 2801-2805, issn 0264-410X, 5 p.Article

Activation of microglia and astrocytes by CpG oligodeoxynucleotidesTAKESHITA, Saoko; TAKESHITA, Fumihiko; HADDAD, Diana E et al.Neuroreport (Oxford). 2001, Vol 12, Num 14, pp 3029-3032, issn 0959-4965Article

Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotidesZEUNER, Rainald A; ISHII, Ken J; LIZAK, Martin J et al.Arthritis and rheumatism. 2002, Vol 46, Num 8, pp 2219-2224, issn 0004-3591Article

Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injuryYASUDA, Hideo; LEELAHAVANICHKUL, Asada; KLINMAN, Dennis M et al.American journal of physiology. Renal physiology. 2008, Vol 63, Num 5, issn 1931-857X, F1050-F1058Article

Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesFOGG, Christiana N; AMERICO, Jeffrey L; LUSTIG, Shiomo et al.Vaccine. 2007, Vol 25, Num 15, pp 2787-2799, issn 0264-410X, 13 p.Article